63
Participants
Start Date
March 22, 2019
Primary Completion Date
December 31, 2020
Study Completion Date
January 4, 2022
Debio 1347
Debio 1347 oral tablets.
National Cheng Kung University Hospital, Tainan City
Philippine General Hospital, Clinical Trial Unit Room 5, Medical Research Laboratory, Ermita
St. Luke's Medical Center, Human Cancer Biobank Research Center, Quezon City
Akershus University Hospital, Lørenskog
"MHAT Serdika, EOOD", Sofia
Landesklinikum Wiener Neustadt, Wiener Neustadt
Herlev Hospital, Herlev
Peninsula and Southeast Oncology (PASO), Frankston
Complex Oncological Center - Plovdiv, EOOD, Plovdiv
John Flynn Private Hospital, Tugun
Odense Universitetshospital, Odense
LKH - Universitätsklinikum der PMU Salzburg, Salzburg
Cebu Doctors' University Hospital (CDUH), Research Office, Cebu City
Linear Clinical Research, B Block Sir Charles Gairdner Hospital, Nedlands
Ålborg Universitets Hospital, Aalborg
MHAT - Dobrich, Dobrich
University Hospital Centre, Sestre Milosrdnice, Zagreb
National Taiwan University Hospital, Taipei
Memorial Sloan-Kettering Hospital, New York
James Graham Brown Cancer Center, Louisville
Memorial Sloan Kettering Cancer Center, Harrison
Taipei Medical University Hospital (TMUH), Taipei
Taipei Veterans General Hospital, Medical Science & Technology Building, Taipei
General Hospital of Athens Laiko, Athens
"General Hospital of Athens of Chest Diseases SOTIRIA", Athens
"General Hospital of Athens Alexandra", Athens
Seoul National University Bundang Hospital, Department of Oncology Medical office, Gyeonggi-do
Thomayerova nemocnice, Prague
West Penn - Allegheny Oncology Network, Pittsburgh
Ajou University Hospital, CRC room, Clinical Trial Center, Suwon
The John Hopkins Hospital, Baltimore
Gachon University Gil Medical Center, CRC Room, 18F, Artificial intelligence hospital, Incheon
Shuang Ho Hospital, New Taipei City
University of North Carolina at Chapel Hill, Chapel Hill
Centro Integral Oncologico Clara Campal, Madrid
CHU Bordeaux - Hôpital Saint André, Groupe Hospitalier Sud - Hôpital Haut-Lévêque, Bordeaux
Linkou Chang-Gung Memorial Hospital, Taoyuan District
Groupe Hospitalier Sud - Hôpital Haut Lévêque, Pessac
H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Taichung Veterans General Hospital, The Radiation Oncology Department, Taichung
General Hospital Varazdin, Varaždin
The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
ICO - Site René Gauducheau, Saint-Herblain
UC Health, LLC., Cincinnati
University General Hospital of Ioannina, Ioannina
Hospital Clinico Universitario de Valencia, Valencia
University of Michigan, Ann Arbor
ICO - Site Paul Papin, Angers
CI Dnipropetrovsk CMCH #4 of Dnipropetrovsk RC Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro
Fakultni nemocnice Hradec Kralove, Hradec Králové
University of Wisconsin, Madison
Centre Oscar Lambret, Lille
SI V.T. Zaycev Institute of general & urgent surgery of National academy medical sciences of Ukraine, Department of purulent surgery, Kharkiv
Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv
Tulane University Cancer Center, New Orleans
CTCA Cancer Treatment Centers, Tulsa
MD Anderson Cancer Center, Houston
University of Utah Hospitals & Clinics, Salt Lake City
Ironwood Cancer & Research Centers - Scottsdale, Scottsdale
University of Arizona Cancer Center, Tucson
Sarcoma Oncology Center, Santa Monica
Moores UCSD Cancer Center, La Jolla
University of California San Francisco, San Francisco
Institut Gustave Roussy, Villejuif
Fred Hutchinson/Seattle Care Alliance, Seattle
"FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow
"SBIH of Arkhangelsk region Arkhangelsk Clinical Oncological Dispensary", Arkhangelsk
Singapore National Cancer Center (SNCC), Singapore
S.C Centrul de Oncologie Sf. Nectarie S.R.L., Craiova
S.C Oncocenter Oncologie Clinica S.R.L., Timișoara
Tan Tock Seng Hospital, Communicable Disease Centre, Singapore
S.C Medisprof S.R.L., Cluj-Napoca
LLC Evimed, Chelyabinsk
Tomsk Research Instutite of Oncology, Tomsk
"BHI of Omsk region Clinical Oncology Dispensary", Omsk
"TSBHI Altai Territorial oncological dispensary", Barnaul
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Memorial Sloan Kettering Cancer Center, Middletown
Rutgers Cancer Institute of New Jersey, New Brunswick
Southern Highlands Private Hospital, Bowral
Hospital de Caridade de Ijuí, Avenida David J Martins, Ijuí
Hospital de Clínicas de Porto Alegre, Rio Grande
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André
ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Avenida Doutor Arnaldo, São Paulo
Fakultni nemocnice u sv. Anny v Brne, Brno
Fakultni nemocnice Olomouc, Olomouc
Fakultni nemocnice Kralovske Vinohrady, Prague
Docrates Syöpäsairaala, Helsinki
Helsinki University Hospital, Helsinki
VU Medisch Centrum, Amsterdam
Haga Ziekenhuis, The Hague
Radiumhospitalet, Montebello, Oslo
Szpital Kliniczny im.Heliodora Swiecickiego Uniwersytetu Medycznego im.K. Marcinkowskiego w Poznaniu, Poznan
MTZ Clinical Research, Warsaw
Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Warsaw
S.C Delta Health Care S.R.L, Bucharest
The Catholic University of Korea, St. Vincent's Hospital, CRC Room, 3F, Gyeonggi-do
Korea University Anam Hospital, Seoul
Seoul National University Hospital (SNUH), Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Ninewells Hospital, Dundee
Guy's Hospital, London
Hammersmith Hospital, London
The Christie, Manchester
Lead Sponsor
Collaborators (1)
Caris Life Sciences
INDUSTRY
Optimal Research (Just In Time sites)
UNKNOWN
Debiopharm International SA
INDUSTRY